LMRINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Lumexa Imaging Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$10.72−0.06 (-0.56%)
Close on Oct 19, 2026
- Market cap
- $1.03B
- P/E (TTM)
- –
- Dividend yield
- –
Lumexa Imaging Holdings, Inc. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q2 25 | Q1 25 | % of revenue | YoY |
|---|---|---|---|---|---|---|
| Outpatient | $196.21M | $187.90M | $187.20M | $180.80M | 74.3% | +4.8% |
| Professional | $72.25M | $68.16M | $66.33M | $65.89M | 27.3% | +8.9% |
| Intersegment Eliminations | -$4.29M | -$3.52M | -$2.12M | -$1.69M | -1.6% | +102.1% |
By product or service
| Revenue | Q2 26 | Q1 26 | Q2 25 | Q1 25 | % of revenue | YoY |
|---|---|---|---|---|---|---|
| Patient Service Revenue | $203.74M | $197.32M | $198.19M | $192.30M | 77.1% | +2.8% |
| Management Fee and Other Revenue [Member] | $60.43M | $55.22M | $53.22M | $52.70M | 22.9% | +13.5% |
| Management Fee and Other Revenue Related Party | $51.72M | $49.54M | $48.40M | $47.38M | 19.6% | +6.9% |
| Patient Service Revenue Related Party | $8.83M | $8.33M | $8.84M | $8.08M | 3.3% | -0.1% |
| Management and Other Revenue | $8.71M | $5.68M | $4.82M | $5.32M | 3.3% | +80.6% |
By region
From the segment and revenue-disaggregation notes of Lumexa Imaging's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.